Astellas Pharma (TSE:4503) Days Sales Outstanding

: 106.39 (As of Dec. 2023)

View and export this data going back to 1949. Start your Free Trial

Astellas Pharma's average Accounts Receivable for the three months ended in Dec. 2023 was 円491,927 Mil. Astellas Pharma's Revenue for the three months ended in Dec. 2023 was 円421,932 Mil. Hence, Astellas Pharma's Days Sales Outstanding for the three months ended in Dec. 2023 was 106.39.

The historical rank and industry rank for Astellas Pharma's Days Sales Outstanding or its related term are showing as below:

TSE:4503' s Days Sales Outstanding Range Over the Past 10 Years
Min: 87.82 Med: 97.08 Max: 110
Current: 110

During the past 13 years, Astellas Pharma's highest Days Sales Outstanding was 110.00. The lowest was 87.82. And the median was 97.08.

TSE:4503's Days Sales Outstanding is ranked worse than
78.7% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 71.685 vs TSE:4503: 110.00

Astellas Pharma's Days Sales Outstanding increased from Dec. 2022 (102.53) to Dec. 2023 (106.39).

Astellas Pharma Days Sales Outstanding Historical Data

The historical data trend for Astellas Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

92.50

96.76

100.81

102.17

97.39

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															102.53	113.24	108.34	110.58	106.39

Competitive Comparison

For the Drug Manufacturers - General subindustry, Astellas Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Days Sales Outstanding falls into.

Astellas Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Astellas Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (382462	+	427965)	/	2 )	/	1518619	*	365
=	405213.5					/	1518619	*	365
=	97.39

Astellas Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (487893	+	495961)	/	2 )	/	421932	*	365 / 4
=	491927					/	421932	*	365 / 4
=	106.39

Astellas Pharma (TSE:4503) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Astellas Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (TSE:4503) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (TSE:4503) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ALPMY:USA ALPMF:USA 4503:Mexico YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Astellas Pharma (TSE:4503) Headlines

No Headlines